Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout.

× No keyword cloud information.

20 in total

1. Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid.

Authors: J Vázquez-Mellado; V Alvarado-Romano; R Burgos-Vargas; A L Jiménez-Vaca; G Pozo-Molina; S A Cuevas-Covarrubias
Journal: J Clin Pathol Date: 2007-08 Impact factor: 3.411

Review 2. Physiology, structure, and regulation of the cloned organic anion transporters.

Authors: C Srimaroeng; J L Perry; J B Pritchard
Journal: Xenobiotica Date: 2008-07 Impact factor: 1.908

Review 3. Gout: a review of nonmodifiable and modifiable risk factors.

Authors: Lindsey A MacFarlane; Seoyoung C Kim
Journal: Rheum Dis Clin North Am Date: 2014-09-02 Impact factor: 2.670

Review 4. New developments in clinically relevant mechanisms and treatment of hyperuricemia.

Authors: Susan J Lee; Robert A Terkeltaub
Journal: Curr Rheumatol Rep Date: 2006-06 Impact factor: 4.592

5. G109T polymorphism of SLC22A12 gene is associated with serum uric acid level, but not with metabolic syndrome.

Authors: Won Cheoul Jang; Youn Hyoung Nam; Young Chang Ahn; Su Min Park; Il Kyu Yoon; Jung-Yoon Choe; Sung-Hoon Park; Minyoung Her; Seong-Kyu Kim
Journal: Rheumatol Int Date: 2011-05-05 Impact factor: 2.631

6. Novel allelic variants and evidence for a prevalent mutation in URAT1 causing renal hypouricemia: biochemical, genetics and functional analysis.

Authors: Blanka Stiburkova; Ivan Sebesta; Kimiyoshi Ichida; Makiko Nakamura; Helena Hulkova; Vladimir Krylov; Lenka Kryspinova; Helena Jahnova
Journal: Eur J Hum Genet Date: 2013-02-06 Impact factor: 4.246

A common mutation in an organic anion transporter gene, SLC22A12, is a suppressing factor for the development of gout.

1. Homozygous frameshift mutation in the SLC22A12 gene in a patient with primary gout and high levels of serum uric acid.

Review 2. Physiology, structure, and regulation of the cloned organic anion transporters.

Review 3. Gout: a review of nonmodifiable and modifiable risk factors.

Review 4. New developments in clinically relevant mechanisms and treatment of hyperuricemia.

5. G109T polymorphism of SLC22A12 gene is associated with serum uric acid level, but not with metabolic syndrome.

6. Novel allelic variants and evidence for a prevalent mutation in URAT1 causing renal hypouricemia: biochemical, genetics and functional analysis.

7. Absence of the SLC22A12 gene mutation in Turkish population with primary gout disease.

8. Functional analysis of novel allelic variants in URAT1 and GLUT9 causing renal hypouricemia type 1 and 2.

Review 9. Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

10. What lies behind serum urate concentration? Insights from genetic and genomic studies.